First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

BACKGROUND: The nadir value of the absolute neutrophil count (ANC) in the first cycle of chemotherapy is an effective predictor of subsequent neutropenic events. This study was designed to validate an earlier published study based on a retrospective data analysis from a prospective randomized clinic...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Rivera, Edgardo, Haim Erder, M, Fridman, Moshe, Frye, Debra, Hortobagyi, Gabriel N
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2003
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC314422/
https://ncbi.nlm.nih.gov/pubmed/12927041
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk